Intech Investment Management LLC Invests $319,000 in Schrödinger, Inc. (NASDAQ:SDGR)

Intech Investment Management LLC bought a new position in Schrödinger, Inc. (NASDAQ:SDGR) in the 3rd quarter, Holdings Channel.com reports. The fund bought 17,194 shares of the company’s stock, valued at approximately $319,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. grew its position in shares of Schrödinger by 5.0% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 13,059 shares of the company’s stock valued at $242,000 after buying an additional 622 shares during the last quarter. Louisiana State Employees Retirement System grew its position in Schrödinger by 2.6% in the 2nd quarter. Louisiana State Employees Retirement System now owns 27,800 shares of the company’s stock worth $538,000 after purchasing an additional 700 shares during the last quarter. GAMMA Investing LLC grew its position in Schrödinger by 49.5% in the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock worth $41,000 after purchasing an additional 703 shares during the last quarter. KBC Group NV grew its position in Schrödinger by 45.4% in the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock worth $47,000 after purchasing an additional 783 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Schrödinger by 145.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock worth $27,000 after purchasing an additional 837 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on SDGR shares. BMO Capital Markets upped their target price on shares of Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Morgan Stanley decreased their target price on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 21st. Three analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.90.

Insider Activity

In other Schrödinger news, insider Margaret Dugan sold 1,531 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total transaction of $27,221.18. Following the sale, the insider now directly owns 13,469 shares in the company, valued at $239,478.82. This represents a 10.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 8.60% of the company’s stock.

Schrödinger Stock Up 1.3 %

Schrödinger stock opened at $22.23 on Thursday. The stock has a market capitalization of $1.62 billion, a PE ratio of -9.50 and a beta of 1.56. Schrödinger, Inc. has a twelve month low of $16.67 and a twelve month high of $38.00. The company has a 50 day moving average of $18.97 and a 200-day moving average of $20.13.

Schrödinger (NASDAQ:SDGR) last announced its earnings results on Tuesday, November 12th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.12). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business had revenue of $35.30 million for the quarter, compared to analyst estimates of $41.25 million. During the same quarter in the previous year, the company posted ($0.86) EPS. The business’s revenue for the quarter was down 17.1% compared to the same quarter last year. Equities analysts anticipate that Schrödinger, Inc. will post -2.29 EPS for the current fiscal year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.